ELAN Q1 2021 Earnings — Elanco Animal Health Incorporated Revenue & Financial Results | Market Cap Arena

ELANElanco Animal Health Incorporated

$12B

Q1 2021 Earnings

Healthcare Drug Manufacturers - Specialty & Generic

Income Statement

Revenue

$1.2B+88.8% YoY

Gross Profit

$526M42.4% margin

Operating Income

$89M7.2% margin

Net Income

-$61M-4.9% margin

EPS (Diluted)

$-0.13

QoQ Revenue Growth

+9.0%

Cash Flow

Operating Cash Flow

$22M

Free Cash Flow

-$34M

Stock-Based Comp.

$15M

Balance Sheet

Total Assets

$17.0B

Total Liabilities

$9.0B

Stockholders' Equity

$8.0B

Cash & Equivalents

$515M

Year-over-Year Comparison

Metric	Current	Year Ago	Change
Revenue	$1.2B	$658M	+88.8%
Gross Profit	$526M	$273M	+92.4%
Operating Income	$89M	$25M	+261.8%
Net Income	-$61M	-$49M	-24.2%

Revenue Segments

Pet Health

$645M52%

Farm Animal

$578M47%

Contract Manufacturing

$19M2%

Geographic Segments

Non-US

$709M57%

UNITED STATES

$533M43%